Biosimilar medicines: A national prescribing framework

Healthcare Improvement Scotland, in collaboration with NHS boards and Area Drug and Therapeutics Committees, has led the development of a national prescribing framework to support the safe, effective and consistent use of biosimilar medicines in NHSScotland.

This prescribing framework is designed for healthcare professionals, including doctors, nurses and pharmacists to support and inform clinical decision-making.

Biosimilar medicines

The European Medicines Agency defines a biosimilar medicine as "a biological medicine that is developed to be similar to an existing biological medicine (the 'reference medicine')". Biological medicines are medicines that are made by or derived from a biological source, such as a bacterium, yeast or blood. They can consist of relatively simple molecules, such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies.

Published Date: 19 May 2015